Brad Ringeisen
InvestorScientific Advisory Board - Innovative Genomics Institute at Medical Excellence Capital
About
Scientific advisor and Executive Director of the Innovative Genomics Institute at UC Berkeley. A physical chemist and former DARPA Biological Technologies Office director.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Eric Heil
Managing Partner at Medical Excellence Capital
Gregg Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
John Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital
Joni Mancini
Managing Partner at Medical Excellence Capital